[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$anab

AnaptysBio shares are soaring after announcing a split into two companies and a $75M buyback program. Positive data from rosnilimab trials and analyst upgrades are fueling the rally.

About $anab

AnaptysBio, Inc. (ANAB) is a biotechnology company focused on developing immunotherapies.

Insights #

$anab engagements is up XXXXXX% from the previous week.

Engagements: XXX #

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXXXX
1 Week: XXXXXX +452%
1 Month: XXXXXX -XX%
6 Months: XXXXXXXXX -XX%
1 Year: XXXXXXXXX +183%
1-Year High: XXXXXX on 2025-02-12
1-Year Low: XX on 2025-05-20

Social Network	X	YouTube
Engagements	XXX	X

Mentions: XX #

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
1 Week: XX -XX%
1 Month: XXX +124%
6 Months: XXXXX +33%
1 Year: XXXXX +250%
1-Year High: XXX on 2025-10-03
1-Year Low: X on 2025-09-14

Social Network	X	YouTube
Mentions	XX	X

Creators: XX #

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning $anab in the last XX hours which is down XX% from XX in the previous XX hours Daily Average: XX
1 Week: XX -XX%
1 Month: XXX +230%
6 Months: XXX +250%
1 Year: XXXXX +373%
1-Year High: XXX on 2025-06-27
1-Year Low: X on 2025-09-14

Sentiment: XX% #

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% -XX%
1 Month: XX% +33%
6 Months: XX% -XX%
1 Year: XX% -XX%
1-Year High: XXX% on 2024-10-11
1-Year Low: XX% on 2025-09-10

Most Supportive Themes

Company Split and Buyback: (40%) Positive sentiment surrounds the announcement of AnaptysBio's split into two companies and a $75M buyback program.
Positive RA Trial Data: (30%) The lead candidate rosnilimab's positive data in rheumatoid arthritis trials is generating excitement.
Analyst Upgrades and Price Targets: (20%) Multiple analysts have raised price targets for $ANAB, indicating confidence in the stock's potential.

Most Critical Themes

Market Competition: (10%) Concerns exist regarding the competitive landscape of the RA treatment market.

Network engagement breakdown:

Network	Positive	%	Neutral	%	Negative	%
X	X	X%	XXX	XXX%	X	X%
YouTube	X	X%	X	X%	X	X%

Total	X	X%	XXX	XXX%	X	X%

Top assets mentioned In the posts about $anab in the last XX hours

Jigstack (STAK2) Carry (CRE) Jigstack (STAK2) Elanco Animal Health Incorporated Common Stock (ELAN) CRISPR Therapeutics AG (CRSP) Perrigo Company PLC (PRGO) Acadia Pharmaceuticals Inc. (ACAD) Agios Pharmaceuticals, Inc. (AGIO) BridgeBio Pharma, Inc. Common Stock (BBIO) BioMarin Pharmaceutical, Inc. (BMRN)

Top topics mentioned In the posts about $anab in the last XX hours

coins defi, coins dao, jigstack, stocks healthcare, $cre, $kavl, $stak, $elan, $crsp, $prgo, $acad, $agio, $bbio, $bmrn, $alks, $qcls, money, stocks technology, stocks, investment, $vygr, $sage, $apge, $bhvn, $pbm, san diego, $xbi, $rna, $crdl, $btai, $entx, $cgem, $mltx, $lac, $rvyl, $litm, $wwr, $sti, $ezgo, $ycbd, bitcoin, coins layer 1, coins bitcoin ecosystem, coins pow, $hond, $ptnm, $gran, $sprb, $cdt, coins solana ecosystem, coins insurance, coins arbitrum, coins avalanche, avis budget group inc, stocks industrials, $car, stocks financial services, $aa, $ame, alcoa corp, stocks basic materials, $bttc, $taxx, youtube, analog devices, $adi, analog, $adpt, $blue, simon, $1099hk, ipo, $zura, $path, $bkkt, stocks crypto treasuries, $spy, nasdaq, united states, $open, $383k, $apld, $eose, $sym, $plug, $ntla